How Can We Distinguish Ventilator-Associated Tracheobronchitis from Pneumonia?

Keane, Seán; Vallecoccia, Maria Sole; Nseir, Saad; Martín‐Loeches, Ignacio

doi:10.1016/j.ccm.2018.08.003

Cited by 18 publications

(13 citation statements)

References 78 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…5) [22,63]. The presence of invasive devices such as endotracheal tubes and antibiotic administration promote pathogenic bacterial colonization due to the overwhelming of local defenses, resulting in the development of an intermediate respiratory infection termed VAT [64]. VAT represents a compartmentalized host response associated with a better overall prognosis compared to VAP, but VAT can prolong the duration of MV and ICU length of stay [65].…”

Section: Epidemiology Of Nosocomial Pulmonary Infections In Ards Patimentioning

confidence: 99%

Pulmonary infections complicating ARDS

et al. 2020

Self Cite

View full text Add to dashboard Cite

Section: Epidemiology Of Nosocomial Pulmonary Infections In Ards Patimentioning

confidence: 99%

Pulmonary infections complicating ARDS

et al. 2020

Self Cite

View full text Add to dashboard Cite

“…This condition has been often described as airway colonization, with microbiological samples yielding Ͻ 10 5 colony-forming units/mL. 4,5,41 The view that is currently accepted by many investigators in the field is that ventilator-associated tracheobronchitis is an intermediate entity between airway colonization and VAP. 41 The estimated incidence of ventilator-associated tracheobronchitis in ICU patients is 2.7-16.5%, with the potential evolution into VAP caused by the same bacterial pathogens.…”

Section: Pathophysiologymentioning

confidence: 99%

“…4,5,41 The view that is currently accepted by many investigators in the field is that ventilator-associated tracheobronchitis is an intermediate entity between airway colonization and VAP. 41 The estimated incidence of ventilator-associated tracheobronchitis in ICU patients is 2.7-16.5%, with the potential evolution into VAP caused by the same bacterial pathogens. There are similar clinical and microbiological characteristics between ventilator-associated tracheobronchitis and VAP, including the presence of hypo-or hyperthermia, abnormal white blood cell counts, and change in respiratory secretions.…”

Section: Pathophysiologymentioning

confidence: 99%

Aerosolized Antibiotics for Treatment of Pneumonia in Mechanically Ventilated Subjects

2019

View full text Add to dashboard Cite

Mechanical ventilation is a well-established and commonly employed modality of treatment for critically ill patients in the ICU. Pneumonia is a frequent complication in mechanically ventilated patients. Patients who develop ventilator-associated pneumonia (VAP) incur higher medical costs, have prolonged ICU and hospital stays, and have increased mortality risk. There is growing interest in finding new treatment modalities for this condition because the success rate for treating VAP with systemic antibiotics continues to be < 70%. Accordingly, clinicians are reevaluating the role of aerosolized antibiotics, either as a sole therapy or as adjuncts to systemic antibiotics, in an attempt to improve clinical outcomes in patients with VAP. There are several clinical settings in which aerosolized antibiotics could be used for treating pneumonia, including their use for prevention, as monotherapy, as adjunctive therapy with systemic antibiotics, and for treatment of extensively drug-resistant or pan drug-resistant pathogens. However, aerosolized antibiotics have not been uniformly effective for improving clinical outcomes of patients with VAP, and local and systemic side effects could complicate their use. Moreover, many questions about aerosolized antibiotics, such as optimal formulations and dosage and treatment regimens, remain unanswered and warrant future investigations.

show abstract

“…Prevalensi pasangan usia subur (PUS) yang menjadi peserta KB berdasarkan data survei demografi dan kesehatan Indonesia (SDKI) pada tahun 2012, menunjukan tingkat kesertaan KB di antara pasangan usia subur mencapai 61,9%. IUD merupakan kontrasepsi yang digunakan oleh 18% wanita usia reproduktif di Asia dan lebih dari 40% di China (5). Berdasarkan informasi data pokok kota Surabaya tahun 2015 jumlah pengikut KB dari tahun 2014 ke tahun 2015 mengalami penurunan.…”

Section: Pendahuluanunclassified

Dukungan Suami Bukan Faktor Utama Kualitas Hidup Akseptor KB IUD

Prastika

Arimi

Pradanie

2019

Pediomaternal Nurs. J.

View full text Add to dashboard Cite

Introduction: The use of low IUD can affect the quality of family life. One of the reasons for using KB is because of the expensive number of children, which is a mayor influence for couples of childbearing ages in improving their welfare. The lower the use of contraception, the lower the quality of life of IUD KB acceptor. The purpose of this study was to explain the relationship between husband’s support and the quality of life of family planning acceptors.Methods: The design of this study is correlational with a cross-sectional approach. The population in this study were acceptors of IUD KB in the Mulyorejo Health Center Surabaya Working Area. The sample of 92 women of childbearing age acceptors of IUD KB was obtained by purposive sampling. Independent partners support variable. The dependent variable is the quality of life status. Data collection using partners support questionnaire and quality of life according to WHOQOL-BREF. Test statistics with Spearman's rho test.Results: There was no significant relationship between lifestyle and quality of life (p = 0.421, r = 0.085).Conclusion: The husband’s most supportive was that they supported the use of family planning. The factor of husband’s support related to quality of life is emotional support, intellectual support, appreciation support, and information support. The majority of respondents can play an independent role in improving their quality of life, starting from making the best decisions for their health in the use of IUD KB. Husband’s support is not always the biggest contributor to improving quality of life, but there are other factors that need to be considered. Further research is needed on other factors related to the quality of life of family planning acceptors.

show abstract

How Can We Distinguish Ventilator-Associated Tracheobronchitis from Pneumonia?

Cited by 18 publications

References 78 publications

Pulmonary infections complicating ARDS

Pulmonary infections complicating ARDS

Aerosolized Antibiotics for Treatment of Pneumonia in Mechanically Ventilated Subjects

Dukungan Suami Bukan Faktor Utama Kualitas Hidup Akseptor KB IUD

Contact Info

Product

Resources

About